MedPath

Effect of ozone therapy in post COVID-19 lung sequels

Not Applicable
Completed
Conditions
Condition 1: Post COVID fibrosis/ inflammatory lung disease. Condition 2: COVID-19 disease.
Abnormal findings on diagnostic imaging of lung
COVID-19, virus identified
U07.1
Registration Number
IRCT20220814055690N1
Lead Sponsor
Bagheiat-allah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
206
Inclusion Criteria

Filling out the informed consent form
Post COVID-19 oxygen dependent patients

Exclusion Criteria

Hypersensitivity to ozone
Albumin less than 3.4
Platelets less than 60,000
Bleeding and coagulation disorders
Uncontrolled hyperthyroidism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.